维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

13篇 您的检索式：作者名="Erba HP"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML)显示文摘	Erba HP Sayar H Juckett M	2013	Invest New Drugs2013，31，4：	1
	2	Phase I1 study of clofarabine monotherapy in previously untreated older adults with acute myeloid leu- kemia and unfavorable prognostic factors 显示文摘	Kantariian HM Erba HP Claxton D	2010	J Clin Oncol2010，28，4：	1
	3	Phase H study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors 显示文摘	Kantarjian HM Erba HP Claxton D	2010	J Clin Oncol2010，28，4：	1
	4	Safety and pharmacokinetics of the antisense oligonucleotide(ASO)LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia(AML)显示文摘	Erba HP Sayar H Juckett M	2013	Invest New Drugs2013，31，4：	1
	5	Prognostic factors in elderly patients with AML and the implications for treatment显示文摘	Erba HP	2007	Hematology Am Soc Hematol Educ Program2007，，：	1
	6	Has there been progress in the treatment of older patients with acute myeloid leukemia?显示文摘	Erba HP	2010	Best Pract Res Clin Haematol2010，23，4：	1
	7	Safety and pharmacokinetics of the antisense oligonucleotide(ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia(AML)显示文摘	Erba HP Sayar H Juckett M		0，，04：	1
	8	Prognostic factors in elderly patients with AML and the implications for treatment显示文摘	Erba HP	2007	Hematol Am Soc Hematol Educ Program2007，207，：	1
	9	Prognostic factors in elderly patients with AMLand the implications for treatment显示文摘	Erba HP	2007	Hematol Am SocHematol Educ Program2007，，：	1
	10	A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia显示文摘	Sekeres MA Maciejewski JP Erba HP	2011	Cancer2011，117，6：	1
	11	Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase:importance of achieving treatment-free remission显示文摘	Erba HP	2015	Am J Hematol2015，90，3：	1
	12	NCCN task force report:molecular markers in leukemias and lymphomas显示文摘	Radich JP Zelenetz AD Chan WC Croce CM Czuczman MS Erba HP Horning SJ Houldsworth J Smith BD Snyder DS Sundar HM Wetzler M Winter JN	2009	J Natl Compr Canc Netw2009，74，：	1
	13	Phase Ⅱ study of single agent clofarabine in previously untreated older adult patients with acute myelogenous leukemia(AML) unlikely to benefit from standard induction chemotherapy显示文摘	Erba HP Kantarjian HM Claxton D	2008	J Clin Oncol2008，26，15：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费